The dna methylation signature of smoking: An archetype for the identification of biomarkers for behavioral illness

Nebraska Symposium on Motivation

Volumn 61, Issue , 2014, Pages 109-127

  Philibert, Robert A ^a   Beach, S R H ^b   Brody, Gene H ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENETIC MARKER;

DNA METHYLATION; EPIGENETICS; GENETIC MARKER; GENETICS; HUMAN; MENTAL DISEASE; PROCEDURES; SMOKING;

DNA METHYLATION; EPIGENOMICS; GENETIC MARKERS; HUMANS; MENTAL DISORDERS; SMOKING;

EID: 84925547471     PISSN: 01467875     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-0653-6_6     Document Type: Article

References (71)

1. Adam, T., McAughey, J., Mocker, C., McGrath, C., & Zimmermann, R. (2010). Influence of filter ventilation on the chemical composition of cigarette mainstream smoke. Analytica Chimica Acta, 657(1), 36–44. doi:http://dx.doi.org/10.1016/j.aca.2009.10.015.
2. Anczak, J. D., & Nogler, R. A. 2nd. (2003). Tobacco cessation in primary care: Maximizing intervention strategies. Clinical Medicine and Research, 1(3), 201–216.
3. Benowitz, N. L. (1996). Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiologic Reviews, 18(2), 188–204.
4. Bock, C., Tomazou, E. M., Brinkman, A. B., Muller, F., Simmer, F., Gu, H., et al. (2010). Quantitative comparison of genome-wide DNA methylation mapping technologies. Nature Biotechnology, 28(10), 1106–1114. doi:10.1038/nbt.1681.
5. Boyd, N. R., Windsor, R. A., Perkins, L. L., & Lowe, J. B. (1998). Quality of measurement of smoking status by self-report and saliva cotinine among pregnant women. Maternal and Child Health Journal, 2(2), 77–83.
6. Breitling, L. P., Yang, R., Korn, B., Burwinkel, B., & Brenner, H. (2011). Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. American Journal of Human Genetics, 88(4), 450–457. doi:10.1016/j.ajhg.2011.03.003.
7. Breitling, L. P., Salzmann, K., Rothenbacher, D., Burwinkel, B., & Brenner, H. (2012). Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease. European Heart Journal, 33, 2841–2848. doi:10.1093/eurheartj/ehs091.
8. Breton, C. V., Byun, H.-M., Wenten, M., Pan, F., Yang, A., & Gilliland, F. D. (2009). Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. American Journal of Respiratory and Critical Care Medicine, 180(5):462–467. doi:10.1164/rccm.200901-0135OC.
9. Britton, G. R., Brinthaupt, J., Stehle, J. M., & James, G. D. (2004). Comparison of self-reported smoking and urinary cotinine levels in a rural pregnant population. Journal of Obstetric, Gynecologic, and Neonatal Nursing: JOGNN/NAACOG, 33(3), 306–311.
10. Caraballo, R. S., Giovino, G. A., & Pechacek, T. F. (2004). Self-reported cigarette smoking vs. serum cotinine among U.S. adolescents. Nicotine and Tobacco Research, 6(1), 19–25. doi:10. 1080/14622200310001656821.
11. Centers for Disease Control & and Prevention. (2008). Smoking-attributable mortality, years of potential life lost, and productivity losses—United States, 2000–2004. MMWR. Morbidity and Mortality Weekly Report, 57(45), 1226–1228.
12. Detich, N., Bovenzi, V., & Szyf, M. (2003). Valproate induces replication-independent active DNA demethylation. Journal of Biological Chemistry, 278(30), 27586–27592. doi:10.1074/ jbc.M303740200.
13. Fan, S., & Zhang, X. (2009). CpG island methylation pattern in different human tissues and its correlation with gene expression. Biochemical and Biophysical Research Communications, 383(4), 421–425.
14. Florescu, A., Ferrence, R., Einarson, T., Selby, P., Soldin, O., & Koren, G. (2009). Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: Focus on developmental toxicology. Therapeutic Drug Monitoring, 31(1), 14–30. 10.1097/FTD.1090b 1013e3181957a3181953b.
15. Fowler, J. S., Volkow, N. D., Wang, G. J., Pappas, N., Logan, J., MacGregor, R., et al. (1996a). Inhibition of monoamine oxidase B in the brains of smokers. Nature, 379(6567), 733–736.
16. Fowler, J. S., Volkow, N. D., Wang, G. J., Pappas, N., Logan, J., Shea, C., et al. (1996b). Brain monoamine oxidase A inhibition in cigarette smokers. Proceedings of the National Academy of Sciences of the United States of America, 93(24), 14065–14069.
17. Frank, J. E., Hoffman, D. S., & Flanagan, V. (1999). Use of repeated cotinine determinations as a motivational and educational tool in smoking cessation counseling for pregnant women. Pediatric Research, 45(4, Part 2 of 2), 197A–197A.
18. Gerrard, M., Gibbons, F. X., Stock, M. L., Lune, L. S., & Cleveland, M. J. (2005). Images of smokers and willingness to smoke among African American pre-adolescents: An application of the prototype/willingness model of adolescent health risk behavior to smoking initiation. Journal of Pediatric Psychology, 30(4), 305–318. doi:10.1093/jpepsy/jsi026.
19. Gorber, S. C., Schofield-Hurwitz, S., Hardt, J., Levasseur, G., & Tremblay, M. (2009). The accuracy of self-reported smoking: A systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine and Tobacco Research, 11(1), 12–24. doi:10.1093/ ntr/ntn010.
20. Gurrieri, F., & Accadia, M. (2009). Genetic imprinting: The paradigm of Prader-Willi and Angelman syndromes. Endocrine Development, 14, 20–28.
21. Hancock, D. B., Artigas, M. S., Gharib, S. A., Henry, A., Manichaikul, A., Ramasamy, A., et al. (2012). Genome-wide joint meta-analysis of SNP and SNP-by-smoking interaction identifies novel loci for pulmonary function. PLoS Genetics, 8(12), e1003098. doi:10.1371/journal. pgen.1003098.
22. Heath, A. C., Kirk, K. M., Meyer, J. M., & Martin, N. G. (1999). Genetic and social determinants of initiation and age at onset of smoking in Australian twins. Behavior Genetics, 29(6), 395–407.
23. Herman, A., & Sofuoglu, M. (2010). Comparison of available treatments for tobacco addiction. Current Psychiatry Reports, 12(5), 433–440. doi:10.1007/s11920-010-0134-6.
24. Hetherington, J., Coutts, R., & Davison, K. (2012). An evaluation of a novel biomarker feedback intervention on smoking cessation: A pilot study. Journal of Smoking Cessation, 7(02), 80–88. doi:10.1017/jsc.2012.16.
25. Ito, K., Lim, S., Caramori, G., Cosio, B., Chung, K. F., Adcock, I. M., & Barnes, P. J. (2002). A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. Proceedings of the National Academy of Sciences of the United States of America, 99(13), 8921–8926. doi:10.1073/pnas.132556899.
26. Jarvis, M. J., Fidler, J., Mindell, J., Feyerabend, C., & West, R. (2008). Assessing smoking status in children, adolescents and adults: Cotinine cut-points revisited. Addiction, 103(9), 1553–1561. doi:10.1111/j.1360-0443.2008.02297.x.
27. Joubert, B. R., Håberg, S. E., Nilsen, R. M., Wang, X., Vollset, S. E., Murphy, S. K., et al. (2012). 450K epigenome-wide scan identifies differential DNA methylation in newborns related to maternal smoking during pregnancy. Environ Health Perspectives, 120, 1425–1431.
28. Kahn, J. R., & Pearlin, L. I. (2006). Financial strain over the life course and health among older adults. Journal of Health and Social Behavior, 47(1), 17–31.doi:10.1177/002214650604700102.
29. Kim-Cohen, J., Caspi, A., Taylor, A., Williams, B., Newcombe, R., Craig, I. W., & Moffitt, T. E. (2006). MAOA, maltreatment, and gene-environment interaction predicting children’s mental health: New evidence and a meta-analysis. Molecular Psychiatry, 11(10), 903–913.
30. Kumar, A., Choi, K.-H., Renthal, W., Tsankova, N. M., Theobald, D. E. H., Truong, H.-T., et al. (2005). Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron, 48(2), 303–314. doi: http://dx.doi.org/10.1016/j.neuron.2005.09.023.
31. Launay, J.-M., Del Pino, M., Chironi, G., Callebert, J., Peoc’h, K., Mégnien, J.-L., et al. (2009). Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation. PLoS One, 4(11), e7959.
32. Lessov, C. N., Martin, N. G., Statham, D. J., Todorov, A. A., Slutske, W. S., Bucholz, K. K., et al. (2004). Defining nicotine dependence for genetic research: Evidence from Australian twins. Psychological Medicine, 34(5), 865–879.
33. Li, M. D. (2006). The genetics of nicotine dependence. Current Psychiatry Reports, 8(2), 158–164.
34. Liu, J. Z., Tozzi, F., Waterworth, D. M., Pillai, S. G., Muglia, P., Middleton, L., et al. (2010). Metaanalysis and imputation refines the association of 15q25 with smoking quantity. Nature Genetics, 42(5), 436–440. doi:http://www.nature.com/ng/journal/v42/n5/suppinfo/ng.572_S1.html.
35. Maes, H. H., Neale, M. C., Kendler, K. S., Martin, N. G., Heath, A. C., & Eaves, L. J. (2006). Genetic and cultural transmission of smoking initiation: An extended twin kinship model. Behavior Genetics, 36(6), 795–808.
36. Manzardo, A. M., Henkhaus, R. S., & Butler, M. G. (2012). Global DNA promoter methylation in frontal cortex of alcoholics and controls. Gene, 498(1), 5–12. doi: http://dx.doi.org/10.1016/j. gene.2012.01.096.
37. McClure, J. B. (2001). Are biomarkers a useful aid in smoking cessation? A review and analysis of the literature. Behavioral Medicine, 27(1), 37–47. doi:10.1080/08964280109595770.
38. Messer, K., Pierce, J. P., Zhu, S.-H., Hartman, A. M., Al-Delaimy, W. K., Trinidad, D. R., & Gilpin, E. A. (2007). The California tobacco control program’s effect on adult smokers: (1) Smoking cessation. Tobacco Control, 16(2), 85–90. doi:10.1136/tc.2006.016873.
39. Meyer, K. D., Saletore, Y., Zumbo, P., Elemento, O., Mason, C. E., & Jaffrey, S. R. (2012). Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons. Cell, 149(7), 1635–1646. doi: http://dx.doi.org/10.1016/j.cell.2012.05.003.
40. Mill, J., Davies, M., Volta, M., Dobson, R., Meaburn, E., Tang, T., & Schalkwyk, L. (2011). Methylomic brain and blood: Brain areas-specific differentially methylated regions, individual differences, and allele specific DNA methylation. Paper presented at the American Society For Human Genetics, Montréal, Canada.
41. Nguyen, L. P., & Bradfield, C. A. (2007). The search for endogenous activators of the aryl hydrocarbon receptor. Chemical Research in Toxicology, 21(1), 102–116. doi:10.1021/tx7001965.
42. Owen, L., & McNeill, A. (2001). Saliva cotinine as indicator of cigarette smoking in pregnant women. Addiction, 96(7), 1001–1006. doi:10.1080/09652140120053057.
43. Park, S.-J., & Nakai, K. (2011). A regression analysis of gene expression in ES cells reveals two gene classes that are significantly different in epigenetic patterns. BMC Bioinformatics, 12(Suppl 1), S50.
44. Philibert, R., Madan, A., Andersen, A., Cadoret, R., Packer, H., & Sandhu, H. (2007). Serotonin transporter mRNA levels are associated with the methylation of an upstream CpG island. American Journal of Medical Genetics, 144B(1), 101–105. doi:10.1002/ajmg.b.30414.
45. Philibert, R. A., Gunter, T. D., Beach, S. R., Brody, G. H., & Madan, A. (2008). MAOA methylation is associated with nicotine and alcohol dependence in women. American Journal of Medical Genetics, 147(5), 565–570. doi:10.1002/ajmg.b.30778.
46. Philibert, R. A., Beach, S. R., Gunter, T. D., Brody, G. H., Madan, A., & Gerrard, M. (2010a). The effect of smoking on MAOA promoter methylation in DNA prepared from lymphoblasts and whole blood. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics, 153(2), 619–628. doi:10.1002/ajmg.b.31031.
47. Philibert, R. A., Beach, S. R., Gunter, T. D., Brody, G. H., Madan, A., & Gerrard, M. (2010b). The effect of smoking on MAOA promoter methylation in DNA prepared from lymphoblasts and whole blood. American Journal of Medical Genetics, 153B(2), 619–628. doi:10.1002/ ajmg.b.31031.
48. Philibert, R. A., Beach, S. R., & Brody, G. H. (2012a). Demethylation of the aryl hydrocarbon receptor repressor as a biomarker for nascent smokers. Epigenetics, 7(11), 1331–1338.
49. Philibert, R. A., Plume, J. M., Gibbons, F. X., Brody, G. H., & Beach, S. R. (2012b). The impact of recent alcohol use on genome wide DNA methylation signatures. Frontiers in Genetics, 3, 54. doi:10.3389/fgene.2012.00054.
50. Philibert, R., Beach, S. R., Li, K.-M., & Brody, G. (2013). Changes in DNA methylation at the aryl hydrocarbon receptor repressor may be a new biomarker for smoking. Journal of Clinical Epigenetics, 5(1), 19.
51. Prom-Wormley, E. C., Eaves, L. J., Foley, D. L., Gardner, C. O., Archer, K. J., Wormley, B. K., et al. (2009). Monoamine oxidase A and childhood adversity as risk factors for conduct disorder in females. Psychological Medicine, 39, 579–590.
52. Shadel, W. G., & Cervone, D. (2011). The role of the self in smoking initiation and smoking cessation: A review and blueprint for research at the intersection of social-cognition and health. Self and Identity, 10(3), 386–395. doi:10.1080/15298868.2011.557922.
53. Shadel, W. G., Shiffman, S., Niaura, R., Nichter, M., & Abrams, D. B. (2000). Current models of nicotine dependence: What is known and what is needed to advance understanding of tobacco etiology among youth. Drug and Alcohol Dependence, 59(Supplement 1), 9–22. doi:10.1016/ s0376-8716(99)00162-3.
54. Shahab, L., West, R., & McNeill, A. (2011). A randomized, controlled trial of adding expired carbon monoxide feedback to brief stop smoking advice: Evaluation of cognitive and behavioral effects. Health Psychology, 30(1), 49–57. doi:10.1037/a0021821.
55. Shaykhiev, R., Krause, A., Salit, J., Strulovici-Barel, Y., Harvey, B. G., O’Connor, T. P., & Crystal, R. G. (2009). Smoking-dependent reprogramming of alveolar macrophage polarization: Implication for pathogenesis of chronic obstructive pulmonary disease. Journal of Immunology, 183(4), 2867–2883.
56. Shenker, N. S., Polidoro, S., van Veldhoven, K., Sacerdote, C., Ricceri, F., Birrell, M. A., et al. (2013). Epigenome-wide association study in the European Prospective Investigation into Can cer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking. Human Molecular Genetics, 22, 843–851. doi:10.1093/hmg/dds488.
57. Shumay, E., Logan, J., Volkow, N. D., & Fowler, J. S. (2012). Evidence that the methylation state of the monoamine oxidase A (MAOA) gene predicts brain activity of MAOA enzyme in healthy men. Epigenetics, 7(10), 10–19.
58. Smith, Z. D., & Meissner, A. (2013). DNA methylation: Roles in mammalian development. Nature Reviews Genetics, 14(3), 204–220.
59. Stevens, K. R., & Munoz, L. R. (2004). Cigarette smoking: Evidence to guide measurement. Research in Nursing and Health, 27(4), 281–292. doi:10.1002/nur.20024.
60. Suzuki, M. M., & Bird, A. (2008). DNA methylation landscapes: Provocative insights from epigenomics. Nature reviews Genetics, 9(6), 465–476. doi:10.1038/nrg2341.
61. Thomassin, H., Oakeley, E. J., & Grange, T. (1999). Identification of 5-methylcytosine in complex genomes. Methods, 19(3), 465–475.
62. True, W. R., Xian, H., Scherrer, J. F., Madden, P. A., Bucholz, K. K., Heath, A. C., et al. (1999). Common genetic vulnerability for nicotine and alcohol dependence in men. Archives of General Psychiatry, 56(7), 655–661.
63. U.S. Department of Health and Human Services. (1990). A report of the surgeon general: The health benefits of smoking cessation. Washington, DC: U.S. Department of Health and Human Services.
64. Van Schooten, F., Godschalk, R., Breedijk, A., Maas, L., Kriek, E., Sakai, H., et al. (1997). 32Ppostlabelling of aromatic DNA adducts in white blood cells and alveolar macrophages of smokers: Saturation at high exposures. Mutation Research, 378(1–2), 65–75.
65. Van Vliet, J., Oates, N., & Whitelaw, E. (2007). Epigenetic mechanisms in the context of complex diseases. Cellular and Molecular Life Sciences, 64(12), 1531–1538.
66. Wannamethee, S. G., Lowe, G. D. O., Shaper, A. G., Rumley, A., Lennon, L., & Whincup, P. H. (2005). Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. European Heart Journal, 26(17), 1765–1773. doi:10.1093/eurheartj/ehi183.
67. Weaving, L. S., Ellaway, C. J., Gecz, J., & Christodoulou, J. (2005). Rett syndrome: Clinical review and genetic update. Journal of Medical Genetics, 42(1), 1–7. doi:10.1136/jmg.2004.027730.
68. Webb, D. A., Boyd, N. R., Messina, D., & Windsor, R. A. (2003). The discrepancy between selfreported smoking status and urine continine levels among women enrolled in prenatal care at four publicly funded clinical sites. Journal of public health management and practice: JPHMP, 9(4), 322–325.
69. Yates, W., Cadoret, R., & Troughton, E. (1998). The Iowa adoption studies methods and results. In M. LaBuda & E. Grigorenko (Eds.), On the way to individuality: Methodological issues in behavioral genetics (pp. 95–125). Hauppauge: Nova Science Publishers.
70. Yawn, B. P., & Kaplan, A. (2008). Co-morbidities in people with COPD: A result of multiple diseases, or multiple manifestations of smoking and reactive inflammation? Primary Care Respiratory Journal: Journal of the General Practice Airways Group, 17(4), 199–205. doi:10.3132/ pcrj.2008.00021.
71. Yu, P. H., & Boulton, A. A. (1987). Irreversible inhibition of monoamine oxidase by some components of cigarette smoke. Life Sciences, 41(6), 675–682.